List of Tables
Table 1. Global Nucleic Acid Transfection Reagents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Nucleic Acid Transfection Reagents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Nucleic Acid Transfection Reagents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Nucleic Acid Transfection Reagents Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nucleic Acid Transfection Reagents Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Nucleic Acid Transfection Reagents Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (L)
Table 7. Global Nucleic Acid Transfection Reagents Sales by Region (2020-2025) & (L)
Table 8. Global Nucleic Acid Transfection Reagents Sales by Region (2026-2031) & (L)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Nucleic Acid Transfection Reagents Sales by Manufacturers (2020-2025) & (L)
Table 11. Global Nucleic Acid Transfection Reagents Sales Share by Manufacturers (2020-2025)
Table 12. Global Nucleic Acid Transfection Reagents Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Nucleic Acid Transfection Reagents Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Nucleic Acid Transfection Reagents by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Transfection Reagents as of 2024)
Table 16. Global Nucleic Acid Transfection Reagents Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Nucleic Acid Transfection Reagents Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/L)
Table 18. Key Manufacturers Nucleic Acid Transfection Reagents Manufacturing Base and Headquarters
Table 19. Global Nucleic Acid Transfection Reagents Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Nucleic Acid Transfection Reagents Sales by Type (2020-2025) & (L)
Table 23. Global Nucleic Acid Transfection Reagents Sales by Type (2026-2031) & (L)
Table 24. Global Nucleic Acid Transfection Reagents Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Nucleic Acid Transfection Reagents Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Nucleic Acid Transfection Reagents ASP by Type (2020-2031) & (US$/L)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Nucleic Acid Transfection Reagents Sales by Application (2020-2025) & (L)
Table 29. Global Nucleic Acid Transfection Reagents Sales by Application (2026-2031) & (L)
Table 30. Nucleic Acid Transfection Reagents High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Nucleic Acid Transfection Reagents Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Nucleic Acid Transfection Reagents Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Nucleic Acid Transfection Reagents ASP by Application (2020-2031) & (US$/L)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Nucleic Acid Transfection Reagents Growth Accelerators and Market Barriers
Table 37. North America Nucleic Acid Transfection Reagents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Nucleic Acid Transfection Reagents Sales (L) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Nucleic Acid Transfection Reagents Growth Accelerators and Market Barriers
Table 40. Europe Nucleic Acid Transfection Reagents Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Nucleic Acid Transfection Reagents Sales (L) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Nucleic Acid Transfection Reagents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Nucleic Acid Transfection Reagents Sales (L) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Nucleic Acid Transfection Reagents Growth Accelerators and Market Barriers
Table 45. Southeast Asia Nucleic Acid Transfection Reagents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Nucleic Acid Transfection Reagents Investment Opportunities and Key Challenges
Table 47. Central and South America Nucleic Acid Transfection Reagents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Nucleic Acid Transfection Reagents Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Nucleic Acid Transfection Reagents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Thermo Fisher Scientific Corporation Information
Table 51. Thermo Fisher Scientific Description and Major Businesses
Table 52. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 53. Thermo Fisher Scientific Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 54. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 55. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 56. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 57. Thermo Fisher Scientific Nucleic Acid Transfection Reagents SWOT Analysis
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. Promega Corporation Information
Table 60. Promega Description and Major Businesses
Table 61. Promega Product Models, Descriptions and Specifications
Table 62. Promega Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 63. Promega Sales Value Proportion by Product in 2024
Table 64. Promega Sales Value Proportion by Application in 2024
Table 65. Promega Sales Value Proportion by Geographic Area in 2024
Table 66. Promega Nucleic Acid Transfection Reagents SWOT Analysis
Table 67. Promega Recent Developments
Table 68. Qiagen Corporation Information
Table 69. Qiagen Description and Major Businesses
Table 70. Qiagen Product Models, Descriptions and Specifications
Table 71. Qiagen Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 72. Qiagen Sales Value Proportion by Product in 2024
Table 73. Qiagen Sales Value Proportion by Application in 2024
Table 74. Qiagen Sales Value Proportion by Geographic Area in 2024
Table 75. Qiagen Nucleic Acid Transfection Reagents SWOT Analysis
Table 76. Qiagen Recent Developments
Table 77. Polyplus-transfection Corporation Information
Table 78. Polyplus-transfection Description and Major Businesses
Table 79. Polyplus-transfection Product Models, Descriptions and Specifications
Table 80. Polyplus-transfection Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 81. Polyplus-transfection Sales Value Proportion by Product in 2024
Table 82. Polyplus-transfection Sales Value Proportion by Application in 2024
Table 83. Polyplus-transfection Sales Value Proportion by Geographic Area in 2024
Table 84. Polyplus-transfection Nucleic Acid Transfection Reagents SWOT Analysis
Table 85. Polyplus-transfection Recent Developments
Table 86. Bio-Rad Laboratories Corporation Information
Table 87. Bio-Rad Laboratories Description and Major Businesses
Table 88. Bio-Rad Laboratories Product Models, Descriptions and Specifications
Table 89. Bio-Rad Laboratories Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 90. Bio-Rad Laboratories Sales Value Proportion by Product in 2024
Table 91. Bio-Rad Laboratories Sales Value Proportion by Application in 2024
Table 92. Bio-Rad Laboratories Sales Value Proportion by Geographic Area in 2024
Table 93. Bio-Rad Laboratories Nucleic Acid Transfection Reagents SWOT Analysis
Table 94. Bio-Rad Laboratories Recent Developments
Table 95. Mirus Bio Corporation Information
Table 96. Mirus Bio Description and Major Businesses
Table 97. Mirus Bio Product Models, Descriptions and Specifications
Table 98. Mirus Bio Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 99. Mirus Bio Recent Developments
Table 100. Sinobiological Corporation Information
Table 101. Sinobiological Description and Major Businesses
Table 102. Sinobiological Product Models, Descriptions and Specifications
Table 103. Sinobiological Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 104. Sinobiological Recent Developments
Table 105. Hanbio Corporation Information
Table 106. Hanbio Description and Major Businesses
Table 107. Hanbio Product Models, Descriptions and Specifications
Table 108. Hanbio Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 109. Hanbio Recent Developments
Table 110. Origene Corporation Information
Table 111. Origene Description and Major Businesses
Table 112. Origene Product Models, Descriptions and Specifications
Table 113. Origene Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 114. Origene Recent Developments
Table 115. Beyotime Corporation Information
Table 116. Beyotime Description and Major Businesses
Table 117. Beyotime Product Models, Descriptions and Specifications
Table 118. Beyotime Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 119. Beyotime Recent Developments
Table 120. Yeasen Biotechnology Corporation Information
Table 121. Yeasen Biotechnology Description and Major Businesses
Table 122. Yeasen Biotechnology Product Models, Descriptions and Specifications
Table 123. Yeasen Biotechnology Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 124. Yeasen Biotechnology Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Nucleic Acid Transfection Reagents Product Picture
Figure 2. Global Nucleic Acid Transfection Reagents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biochemical Transfection Product Picture
Figure 4. Physical Transfection Product Picture
Figure 5. Global Nucleic Acid Transfection Reagents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Fundamental Research
Figure 7. Drug Development and Production
Figure 8. Nucleic Acid Transfection Reagents Report Years Considered
Figure 9. Global Nucleic Acid Transfection Reagents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 11. Global Nucleic Acid Transfection Reagents Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Nucleic Acid Transfection Reagents Revenue Market Share by Region (2020-2031)
Figure 13. Global Nucleic Acid Transfection Reagents Sales (2020-2031) & (L)
Figure 14. Global Nucleic Acid Transfection Reagents Sales (CAGR) by Region (2020-2031) (L)
Figure 15. Global Nucleic Acid Transfection Reagents Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Nucleic Acid Transfection Reagents Sales Volume Market Share in 2024
Figure 17. Global Nucleic Acid Transfection Reagents Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Biochemical Transfection Revenue Market Share by Manufacturer in 2024
Figure 20. Physical Transfection Revenue Market Share by Manufacturer in 2024
Figure 21. Global Nucleic Acid Transfection Reagents Sales Market Share by Type (2020-2031)
Figure 22. Global Nucleic Acid Transfection Reagents Revenue Market Share by Type (2020-2031)
Figure 23. Global Nucleic Acid Transfection Reagents Sales Market Share by Application (2020-2031)
Figure 24. Global Nucleic Acid Transfection Reagents Revenue Market Share by Application (2020-2031)
Figure 25. North America Nucleic Acid Transfection Reagents Sales YoY (2020-2031) & (L)
Figure 26. North America Nucleic Acid Transfection Reagents Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) in 2024
Figure 28. North America Nucleic Acid Transfection Reagents Sales Volume (L) by Type (2020- 2031)
Figure 29. North America Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Nucleic Acid Transfection Reagents Sales Volume (L) by Application (2020-2031)
Figure 31. North America Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Nucleic Acid Transfection Reagents Sales YoY (2020-2031) & (L)
Figure 36. Europe Nucleic Acid Transfection Reagents Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) in 2024
Figure 38. Europe Nucleic Acid Transfection Reagents Sales Volume (L) by Type (2020-2031)
Figure 39. Europe Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Nucleic Acid Transfection Reagents Sales Volume (L) by Application (2020-2031)
Figure 41. Europe Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 43. France Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Nucleic Acid Transfection Reagents Sales YoY (2020-2031) & (L)
Figure 48. Asia-Pacific Nucleic Acid Transfection Reagents Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Nucleic Acid Transfection Reagents Sales Volume (L) by Type (2020- 2031)
Figure 51. Asia-Pacific Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Nucleic Acid Transfection Reagents Sales Volume (L) by Application (2020-2031)
Figure 53. Asia-Pacific Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 58. India Nucleic Acid Transfection Reagents Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Nucleic Acid Transfection Reagents Sales YoY (2020-2031) & (L)
Figure 60. Central and South America Nucleic Acid Transfection Reagents Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Nucleic Acid Transfection Reagents Sales Volume (L) by Type (2021-2031)
Figure 63. Central and South America Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Nucleic Acid Transfection Reagents Sales Volume (L) by Application (2020-2031)
Figure 65. Central and South America Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Nucleic Acid Transfection Reagents Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Nucleic Acid Transfection Reagents Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Nucleic Acid Transfection Reagents Sales YoY (2020-2031) & (L)
Figure 69. Middle East and Africa Nucleic Acid Transfection Reagents Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Nucleic Acid Transfection Reagents Sales Volume (L) by Type (2021-2031)
Figure 72. South America Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Nucleic Acid Transfection Reagents Sales Volume (L) by Application (2020-2031)
Figure 74. Middle East and Africa Nucleic Acid Transfection Reagents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Nucleic Acid Transfection Reagents Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Nucleic Acid Transfection Reagents Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Nucleic Acid Transfection Reagents Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Nucleic Acid Transfection Reagents Revenue (2020-2025) & (US$ Million)
Figure 79. Nucleic Acid Transfection Reagents Industry Chain Mapping
Figure 80. Regional Nucleic Acid Transfection Reagents Manufacturing Base Distribution (%)
Figure 81. Global Nucleic Acid Transfection Reagents Production Market Share by Region (2020-2031)
Figure 82. Nucleic Acid Transfection Reagents Production Process
Figure 83. Regional Nucleic Acid Transfection Reagents Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
